Table 2. Clinical details of the studied patients.
| AHB (n = 19) | CHB-IT (n = 10) | CHB-IC (n = 59) | CHB-LR (n = 8) | CHB-ENG (n = 24) | P value | |
| Gender (M/F) | 15/4 | 7/3 | 49/10 | 4/4 | 17/7 | 0.257 |
| Age (years) | 32 (24–41) | 18 (10–34) | 30 (14–43) | 30 (15–42) | 35 (23–41) | 0.332 |
| TBil (µmol/L) | 122 (33.9–171.5) | 8.4 (5.7–13.1) | 12.2 (8.6–24.6) | 10.7 (7.8–12.8) | 15.0 (8.8–20.4) | <0.001 |
| Albumin (g/L) | 39 (36–41) | 40 (38–41) | 40 (37–43) | 39 (38–42.3) | 41 (38–46) | 0.330 |
| Albumin/globulin | 1.4 (1.2–1.8) | 1.7 (1.4–1.9) | 1.6 (1.3–1.9) | 1.5 (1.4–1.8) | 1.6 (1.3–1.9) | 0.871 |
| Cholinesterase (IU/L) | 5661(4270–7225) | 7662 (6091–8634) | 5899 (4827–7364) | 7920 (5788–9544) | 6332 (5127–7851) | 0.210 |
| ALT (IU/L) | 1571(1014–2142) | 33 (17–39) | 132 (62–398) | 20 (17–32) | 138 (63–346) | <0.001 |
| HBV DNA (log10 IU/mL) | 3.88 (2.87–4.80) | 7.95 (7.35–8.32) | 6.43 (4.86–7.84) | 3.08 (2.44–3.14) | 6.1 (5.21–8.01) | <0.001 |
| HBeAg | Positive | Positive | Positive | Negative | Negative | |
| HBV genotype (B/C) | 7/12 | 2/8 | 11/48 | 1/7 | 4/20 |